Article(id=1330225939688043355, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225816673301282, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2022.07.021, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1626192000000, receivedDateStr=2021-07-14, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795080178423, onlineDateStr=2026-11-19, pubDate=1657382400000, pubDateStr=2022-07-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795080178423, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795080178423, creator=13701087609, updateTime=1795080178423, updator=13701087609, issue=Issue{id=1330225816673301282, tenantId=1146029695717560320, journalId=1319690329412173987, year='2022', volume='43', issue='7', pageStart='815', pageEnd='956', issueExtLink='null', onlineDate='null', pubDate='1657382400000', pubDateStr='2022-07-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795080149094, creator='13701087609', updateTime=1795084753930, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330245131388695240, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225816673301282, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330245131388695241, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225816673301282, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=932, endPage=938, ext={EN=ArticleExt(id=1330225941441262428, articleId=1330225939688043355, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Progress on the study of therapeutic drugs for Sjögren syndrome, columnId=1325221194584162830, journalTitle=World Clinical Drug, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

Sjögren syndrome (SS) is a chronic autoimmune disease characterized by destruction of exocrine glandular epithelium and severe drying of mucosal surface, with complex etiology. It is difficult to diagnose SS accurately because of its extensive manifestations and overlapping of signs and symptoms with other autoimmune diseases. At present, substitution and symptomatic treatment are mainly used in clinic to delay the disease and improve symptoms, but the effect is often not ideal, and there is no radical cure. In recent years, with the continuous development of various targeted drugs, some new theatments and means have emerged in the clinical treatment of SS. This article reviewed the therapeutic drugs of SS in recent years in order to provide reference for clinical medication.

, authors=Lili SUN, Yanyan ZHANG, Mianli PAN, Longhai SHEN*, authorsList=Lili SUN, Yanyan ZHANG, Mianli PAN, Longhai SHEN, authorCompany=null, correspAuthors=Longhai SHEN, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330225941650977629, articleId=1330225939688043355, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=干燥综合征治疗药物研究进展, columnId=1325221194743546384, journalTitle=世界临床药物, columnName=综述评论, runingTitle=null, highlight=null, articleAbstract=

干燥综合征(Sjögren syndrome,SS)是一种以外分泌腺上皮破坏、黏膜表面严重干燥为特征的慢性自身免疫性疾病,病因复杂。因SS表现广泛,与其他自身免疫性疾病的体征及症状重叠,故其准确诊断难度较大。目前,临床主要采用替代和对症治疗延缓病情,改善症状,但效果常不理想,且尚无根治方法。近年来,随着各种靶向药物的不断研发,出现了一些新的治疗方法及手段。现就近年来SS治疗药物作一综述,以期为临床用药提供一定参考。

, authors=孙丽丽, 张艳艳, 潘绵立, 沈龙海*, authorsList=孙丽丽, 张艳艳, 潘绵立, 沈龙海, authorCompany=null, correspAuthors=沈龙海, authorNote=

孙丽丽,硕士研究生,研究方向:免疫药理学。

, correspAuthorsNote=
沈龙海,研究员,研究方向:免疫药理学。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=vUrkvuE0Y0Oj8998ZkaWsw==, magXml=dSramSFcBJkTIlvdbyKtpQ==, pdfUrl=null, pdf=bY/7gYFvNJ6fCAS4yfXbEA==, pdfFileSize=1713385, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=R69iTycacSg0FZdHODacHw==, mapNumber=null, fund=null)}, authors=[Author(id=1330225941936190306, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225942011687780, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, authorId=1330225941936190306, language=EN, stringName=Lili SUN, firstName=Lili, middleName=null, lastName=SUN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Shanghai Pharmaceutical Industry Research Institute Co., Ltd, State Key Laboratory of New Drug and Pharmaceutical Process-Shanghai Professional and Technical Service Center for Biological Material Drug Gability Evaluation, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai Biomaterial Drug Evaluation and Professional Technical Service Platform, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225942074602341, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, authorId=1330225941936190306, language=CN, stringName=孙丽丽, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海医药工业研究院有限公司,上海医药工业研究院创新药物与制药工艺国家重点实验室,上海市生物物质成药性评价和专业技术服务平台,上海 200437, bio={"content":"

孙丽丽,硕士研究生,研究方向:免疫药理学。

"}, bioImg=null, bioContent=

孙丽丽,硕士研究生,研究方向:免疫药理学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225941860692830, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, xref=null, ext=[AuthorCompanyExt(id=1330225941869081439, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, companyId=1330225941860692830, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shanghai Pharmaceutical Industry Research Institute Co., Ltd, State Key Laboratory of New Drug and Pharmaceutical Process-Shanghai Professional and Technical Service Center for Biological Material Drug Gability Evaluation, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai Biomaterial Drug Evaluation and Professional Technical Service Platform, Shanghai 200437, China), AuthorCompanyExt(id=1330225941877470048, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, companyId=1330225941860692830, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海医药工业研究院有限公司,上海医药工业研究院创新药物与制药工艺国家重点实验室,上海市生物物质成药性评价和专业技术服务平台,上海 200437)])]), Author(id=1330225942141711207, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225942225597289, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, authorId=1330225942141711207, language=EN, stringName=Yanyan ZHANG, firstName=Yanyan, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Shanghai Pharmaceutical Industry Research Institute Co., Ltd, State Key Laboratory of New Drug and Pharmaceutical Process-Shanghai Professional and Technical Service Center for Biological Material Drug Gability Evaluation, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai Biomaterial Drug Evaluation and Professional Technical Service Platform, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225942301094762, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, authorId=1330225942141711207, language=CN, stringName=张艳艳, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海医药工业研究院有限公司,上海医药工业研究院创新药物与制药工艺国家重点实验室,上海市生物物质成药性评价和专业技术服务平台,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225941860692830, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, xref=null, ext=[AuthorCompanyExt(id=1330225941869081439, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, companyId=1330225941860692830, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shanghai Pharmaceutical Industry Research Institute Co., Ltd, State Key Laboratory of New Drug and Pharmaceutical Process-Shanghai Professional and Technical Service Center for Biological Material Drug Gability Evaluation, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai Biomaterial Drug Evaluation and Professional Technical Service Platform, Shanghai 200437, China), AuthorCompanyExt(id=1330225941877470048, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, companyId=1330225941860692830, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海医药工业研究院有限公司,上海医药工业研究院创新药物与制药工艺国家重点实验室,上海市生物物质成药性评价和专业技术服务平台,上海 200437)])]), Author(id=1330225942380786540, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225942473061230, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, authorId=1330225942380786540, language=EN, stringName=Mianli PAN, firstName=Mianli, middleName=null, lastName=PAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Shanghai Pharmaceutical Industry Research Institute Co., Ltd, State Key Laboratory of New Drug and Pharmaceutical Process-Shanghai Professional and Technical Service Center for Biological Material Drug Gability Evaluation, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai Biomaterial Drug Evaluation and Professional Technical Service Platform, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225942540170095, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, authorId=1330225942380786540, language=CN, stringName=潘绵立, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海医药工业研究院有限公司,上海医药工业研究院创新药物与制药工艺国家重点实验室,上海市生物物质成药性评价和专业技术服务平台,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225941860692830, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, xref=null, ext=[AuthorCompanyExt(id=1330225941869081439, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, companyId=1330225941860692830, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shanghai Pharmaceutical Industry Research Institute Co., Ltd, State Key Laboratory of New Drug and Pharmaceutical Process-Shanghai Professional and Technical Service Center for Biological Material Drug Gability Evaluation, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai Biomaterial Drug Evaluation and Professional Technical Service Platform, Shanghai 200437, China), AuthorCompanyExt(id=1330225941877470048, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, companyId=1330225941860692830, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海医药工业研究院有限公司,上海医药工业研究院创新药物与制药工艺国家重点实验室,上海市生物物质成药性评价和专业技术服务平台,上海 200437)])]), Author(id=1330225942603084658, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330225942665999220, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, authorId=1330225942603084658, language=EN, stringName=Longhai SHEN, firstName=Longhai, middleName=null, lastName=SHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Shanghai Pharmaceutical Industry Research Institute Co., Ltd, State Key Laboratory of New Drug and Pharmaceutical Process-Shanghai Professional and Technical Service Center for Biological Material Drug Gability Evaluation, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai Biomaterial Drug Evaluation and Professional Technical Service Platform, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225942783439733, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, authorId=1330225942603084658, language=CN, stringName=沈龙海, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=上海医药工业研究院有限公司,上海医药工业研究院创新药物与制药工艺国家重点实验室,上海市生物物质成药性评价和专业技术服务平台,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225941860692830, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, xref=null, ext=[AuthorCompanyExt(id=1330225941869081439, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, companyId=1330225941860692830, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shanghai Pharmaceutical Industry Research Institute Co., Ltd, State Key Laboratory of New Drug and Pharmaceutical Process-Shanghai Professional and Technical Service Center for Biological Material Drug Gability Evaluation, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai Biomaterial Drug Evaluation and Professional Technical Service Platform, Shanghai 200437, China), AuthorCompanyExt(id=1330225941877470048, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, companyId=1330225941860692830, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海医药工业研究院有限公司,上海医药工业研究院创新药物与制药工艺国家重点实验室,上海市生物物质成药性评价和专业技术服务平台,上海 200437)])])], keywords=[Keyword(id=1330225942884103030, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, language=EN, orderNo=1, keyword=Sjögren syndrome), Keyword(id=1330225942963794807, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, language=EN, orderNo=2, keyword=autoimmune disease), Keyword(id=1330225943026709368, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, language=EN, orderNo=3, keyword=targeted drug), Keyword(id=1330225943089623929, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, language=CN, orderNo=1, keyword=干燥综合征), Keyword(id=1330225943156732794, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, language=CN, orderNo=2, keyword=自身免疫性疾病), Keyword(id=1330225943215453051, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, language=CN, orderNo=3, keyword=靶向药物)], refs=[Reference(id=1330225943349670780, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Yue X, Deng F, Chen J, et al. Autoantibodies against C5aR1, C3aR1, CXCR3, and CXCR4 are decreased in primary Sjögren's syndrome[J]. Mol Immunol, 2021, 131: 112-120., articleTitle=null, refAbstract=null), Reference(id=1330225943416779645, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Fisher BM, Brown RM, Bowman SJ, et al. A review of salivary gland histopathology in primary Sjögren's syndrome with a focus on its potential as a clinical trials biomarker[J]. Ann Rheum Dis, 2015, 74(9): 1645-1650., articleTitle=null, refAbstract=null), Reference(id=1330225943475499902, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Luo D, Chen Y, Zhou N, et al. Blockade of Th17 response by IL-38 in primary Sjögren's syndrome[J]. Mol Immunol, 2020, 127: 107-111., articleTitle=null, refAbstract=null), Reference(id=1330225943534220159, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Rui K, Hong Y, Zhu Q, et al. Olfactory ecto-mesenchymal stem cell-derived exosomes ameliorate murine Sjögren's syndrome by modulating the function of myeloid-derived suppressor cells[J]. Cell Mol Immunol, 2021, 18(2): 440-451., articleTitle=null, refAbstract=null), Reference(id=1330225943597134720, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Wieczorek G, Bigaud M, Pfister S, et al. Blockade of CD40-CD154 pathway interactions suppresses ectopic lymphoid structures and inhibits pathology in the NOD/ShiLtJ mouse model of Sjögren's syndrome[J]. Ann Rheum Dis, 2019, 78(7): 974-978., articleTitle=null, refAbstract=null), Reference(id=1330225943660049281, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Qin B, Wang J, Yang Z, et al. Epidemiology of primary Sjögren's syndrome: a systematic review and meta-analysis[J]. Ann Rheum Dis, 2015, 74(11): 1983-1989., articleTitle=null, refAbstract=null), Reference(id=1330225943727158146, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Mavragani CP. Mechanisms and new strategies for primary Sjögren's syndrome[J]. Annu Rev Med, 2017, 68: 331-343., articleTitle=null, refAbstract=null), Reference(id=1330225943790072707, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Betül Türkoğlu E, Tuna S, Alan S, et al. Effect of systemic infiximab therapy in patients with Sjögren's syndrome[J]. Turk J Ophthalmol, 2015, 45(4): 138-141., articleTitle=null, refAbstract=null), Reference(id=1330225943852987268, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=St Clair EW, Baer AN, Wei C, et al. The clinical efficacy and safety of baminercept, a lymphotoxin-β receptor fusion protein, in primary Sjögren's syndrome: results from a randomized, double-blind, placebo-controlled phase Ⅱ trial[J]. Arthritis Rheumatol, 2018, 70(9): 1470-1480., articleTitle=null, refAbstract=null), Reference(id=1330225943915901829, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Nakahara H, Kawamoto K, Mori H, et al. AB0485 tocilizumab is effective for the patient with Sjogren's syndrome complicated with rheumatoid arthritis[J]. Ann Rheum Dis, 2014, 73(Suppl 2): 967-968., articleTitle=null, refAbstract=null), Reference(id=1330225943983010694, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Marino A, Narula S, Lerman MA. First pediatric patient with neuromyelitis optica and Sjögren's syndrome successfully treated with tocilizumab[J]. Pediatr Neurol, 2017, 73: e5-e6., articleTitle=null, refAbstract=null), Reference(id=1330225944041730951, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Maier-Moore JS, Horton CG, Mathews SA, et al. Interleukin-6 deficiency corrects nephritis, lymphocyte abnormalities, and secondary Sjögren's syndrome features in lupus-prone Sle1. Yaa mice[J]. Arthritis Rheumatol, 2014, 66(9): 2521-2531., articleTitle=null, refAbstract=null), Reference(id=1330225944108839816, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Barone F, Nayar S, Campos J, et al. IL-22 regulates lymphoid chemokine production and assembly of tertiary lymphoid organs[J]. Proc Natl Acad Sci USA, 2015, 112(35): 11024-11029., articleTitle=null, refAbstract=null), Reference(id=1330225945723646857, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Bowman SJ, Everett CC, O'Dwyer JL, et al. Randomized controlled trial of rituximab and cost-effectiveness analysis in treating fatigue and oral dryness in primary Sjögren's syndrome[J]. Arthritis Rheumatol, 2017, 69(7): 1440-1450., articleTitle=null, refAbstract=null), Reference(id=1330225945815921546, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Mekinian A, Ravaud P, Hatron PY, et al. Efficacy of rituximab in primary Sjögren's syndrome with peripheral nervous system involvement: results from the AIR registry[J]. Ann Rheum Dis, 2012, 71(1): 84-87., articleTitle=null, refAbstract=null), Reference(id=1330225945950139275, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Steinfeld SD, Tant L, Burmester GR, et al. Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase Ⅰ/Ⅱ study[J]. Arthritis Res Ther, 2006, 8(4): R129., articleTitle=null, refAbstract=null), Reference(id=1330225946017248140, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Mariette X, Seror R, Quartuccio L, et al. Efficacy and safety of belimumab in primary Sjögren's syndrome: results of the BELISS open-label phase Ⅱ study[J]. Ann Rheum Dis, 2015, 74(3): 526-531., articleTitle=null, refAbstract=null), Reference(id=1330225946096939917, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Tsuboi H, Matsumoto I, Hagiwara S, et al. Efficacy and safety of abatacept for patients with Sjögren's syndrome associated with rheumatoid arthritis: rheumatoid arthritis with orencia trial toward Sjögren's syndrome endocrinopathy (ROSE) trial-an open-label, one-year, prospective study- interim analysis of 32 patients for 24 weeks[J]. Mod Rheumatol, 2015, 25(2): 187-193., articleTitle=null, refAbstract=null), Reference(id=1330225946155660174, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Corneth OBJ, Verstappen GMP, Paulissen SMJ, et al. Enhanced Bruton's tyrosine kinase activity in peripheral blood B lymphocytes of autoimmune disease patients[J]. Arthritis Rheumatol, 2017, 69(6): 1313-1324., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1330225941860692830, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, xref=null, ext=[AuthorCompanyExt(id=1330225941869081439, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, companyId=1330225941860692830, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shanghai Pharmaceutical Industry Research Institute Co., Ltd, State Key Laboratory of New Drug and Pharmaceutical Process-Shanghai Professional and Technical Service Center for Biological Material Drug Gability Evaluation, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai Biomaterial Drug Evaluation and Professional Technical Service Platform, Shanghai 200437, China), AuthorCompanyExt(id=1330225941877470048, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, companyId=1330225941860692830, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海医药工业研究院有限公司,上海医药工业研究院创新药物与制药工艺国家重点实验室,上海市生物物质成药性评价和专业技术服务平台,上海 200437)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2022.07.021, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.07.021, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2022.07.021, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2022.07.021, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1657382400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
干燥综合征治疗药物研究进展
孙丽丽 , 张艳艳 , 潘绵立 , 沈龙海 *
世界临床药物 | 综述评论 2022,43(7): 932-938
收起
收藏切换
世界临床药物 |综述评论 2022 , 43 (7) : 932 -938
干燥综合征治疗药物研究进展
全屏
[Author(id=1330225941936190306, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225942011687780, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, authorId=1330225941936190306, language=EN, stringName=Lili SUN, firstName=Lili, middleName=null, lastName=SUN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Shanghai Pharmaceutical Industry Research Institute Co., Ltd, State Key Laboratory of New Drug and Pharmaceutical Process-Shanghai Professional and Technical Service Center for Biological Material Drug Gability Evaluation, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai Biomaterial Drug Evaluation and Professional Technical Service Platform, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225942074602341, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, authorId=1330225941936190306, language=CN, stringName=孙丽丽, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海医药工业研究院有限公司,上海医药工业研究院创新药物与制药工艺国家重点实验室,上海市生物物质成药性评价和专业技术服务平台,上海 200437, bio={"content":"

孙丽丽,硕士研究生,研究方向:免疫药理学。

"}, bioImg=null, bioContent=

孙丽丽,硕士研究生,研究方向:免疫药理学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225941860692830, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, xref=null, ext=[AuthorCompanyExt(id=1330225941869081439, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, companyId=1330225941860692830, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shanghai Pharmaceutical Industry Research Institute Co., Ltd, State Key Laboratory of New Drug and Pharmaceutical Process-Shanghai Professional and Technical Service Center for Biological Material Drug Gability Evaluation, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai Biomaterial Drug Evaluation and Professional Technical Service Platform, Shanghai 200437, China), AuthorCompanyExt(id=1330225941877470048, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, companyId=1330225941860692830, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海医药工业研究院有限公司,上海医药工业研究院创新药物与制药工艺国家重点实验室,上海市生物物质成药性评价和专业技术服务平台,上海 200437)])]), Author(id=1330225942141711207, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225942225597289, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, authorId=1330225942141711207, language=EN, stringName=Yanyan ZHANG, firstName=Yanyan, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Shanghai Pharmaceutical Industry Research Institute Co., Ltd, State Key Laboratory of New Drug and Pharmaceutical Process-Shanghai Professional and Technical Service Center for Biological Material Drug Gability Evaluation, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai Biomaterial Drug Evaluation and Professional Technical Service Platform, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225942301094762, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, authorId=1330225942141711207, language=CN, stringName=张艳艳, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海医药工业研究院有限公司,上海医药工业研究院创新药物与制药工艺国家重点实验室,上海市生物物质成药性评价和专业技术服务平台,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225941860692830, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, xref=null, ext=[AuthorCompanyExt(id=1330225941869081439, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, companyId=1330225941860692830, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shanghai Pharmaceutical Industry Research Institute Co., Ltd, State Key Laboratory of New Drug and Pharmaceutical Process-Shanghai Professional and Technical Service Center for Biological Material Drug Gability Evaluation, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai Biomaterial Drug Evaluation and Professional Technical Service Platform, Shanghai 200437, China), AuthorCompanyExt(id=1330225941877470048, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, companyId=1330225941860692830, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海医药工业研究院有限公司,上海医药工业研究院创新药物与制药工艺国家重点实验室,上海市生物物质成药性评价和专业技术服务平台,上海 200437)])]), Author(id=1330225942380786540, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225942473061230, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, authorId=1330225942380786540, language=EN, stringName=Mianli PAN, firstName=Mianli, middleName=null, lastName=PAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Shanghai Pharmaceutical Industry Research Institute Co., Ltd, State Key Laboratory of New Drug and Pharmaceutical Process-Shanghai Professional and Technical Service Center for Biological Material Drug Gability Evaluation, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai Biomaterial Drug Evaluation and Professional Technical Service Platform, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225942540170095, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, authorId=1330225942380786540, language=CN, stringName=潘绵立, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海医药工业研究院有限公司,上海医药工业研究院创新药物与制药工艺国家重点实验室,上海市生物物质成药性评价和专业技术服务平台,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225941860692830, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, xref=null, ext=[AuthorCompanyExt(id=1330225941869081439, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, companyId=1330225941860692830, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shanghai Pharmaceutical Industry Research Institute Co., Ltd, State Key Laboratory of New Drug and Pharmaceutical Process-Shanghai Professional and Technical Service Center for Biological Material Drug Gability Evaluation, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai Biomaterial Drug Evaluation and Professional Technical Service Platform, Shanghai 200437, China), AuthorCompanyExt(id=1330225941877470048, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, companyId=1330225941860692830, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海医药工业研究院有限公司,上海医药工业研究院创新药物与制药工艺国家重点实验室,上海市生物物质成药性评价和专业技术服务平台,上海 200437)])]), Author(id=1330225942603084658, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330225942665999220, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, authorId=1330225942603084658, language=EN, stringName=Longhai SHEN, firstName=Longhai, middleName=null, lastName=SHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Shanghai Pharmaceutical Industry Research Institute Co., Ltd, State Key Laboratory of New Drug and Pharmaceutical Process-Shanghai Professional and Technical Service Center for Biological Material Drug Gability Evaluation, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai Biomaterial Drug Evaluation and Professional Technical Service Platform, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225942783439733, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, authorId=1330225942603084658, language=CN, stringName=沈龙海, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=上海医药工业研究院有限公司,上海医药工业研究院创新药物与制药工艺国家重点实验室,上海市生物物质成药性评价和专业技术服务平台,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225941860692830, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, xref=null, ext=[AuthorCompanyExt(id=1330225941869081439, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, companyId=1330225941860692830, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shanghai Pharmaceutical Industry Research Institute Co., Ltd, State Key Laboratory of New Drug and Pharmaceutical Process-Shanghai Professional and Technical Service Center for Biological Material Drug Gability Evaluation, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai Biomaterial Drug Evaluation and Professional Technical Service Platform, Shanghai 200437, China), AuthorCompanyExt(id=1330225941877470048, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225939688043355, companyId=1330225941860692830, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海医药工业研究院有限公司,上海医药工业研究院创新药物与制药工艺国家重点实验室,上海市生物物质成药性评价和专业技术服务平台,上海 200437)])])]
孙丽丽, 张艳艳, 潘绵立, 沈龙海*
作者信息
  • 上海医药工业研究院有限公司,上海医药工业研究院创新药物与制药工艺国家重点实验室,上海市生物物质成药性评价和专业技术服务平台,上海 200437
通讯作者:
沈龙海,研究员,研究方向:免疫药理学。
作者简介:

孙丽丽,硕士研究生,研究方向:免疫药理学。

Progress on the study of therapeutic drugs for Sjögren syndrome
Lili SUN, Yanyan ZHANG, Mianli PAN, Longhai SHEN*
Affiliations
  • Shanghai Pharmaceutical Industry Research Institute Co., Ltd, State Key Laboratory of New Drug and Pharmaceutical Process-Shanghai Professional and Technical Service Center for Biological Material Drug Gability Evaluation, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai Biomaterial Drug Evaluation and Professional Technical Service Platform, Shanghai 200437, China
出版时间: 2022-07-10 doi: 10.13683/j.wph.2022.07.021
文章导航
收藏切换

干燥综合征(Sjögren syndrome,SS)是一种以外分泌腺上皮破坏、黏膜表面严重干燥为特征的慢性自身免疫性疾病,病因复杂。因SS表现广泛,与其他自身免疫性疾病的体征及症状重叠,故其准确诊断难度较大。目前,临床主要采用替代和对症治疗延缓病情,改善症状,但效果常不理想,且尚无根治方法。近年来,随着各种靶向药物的不断研发,出现了一些新的治疗方法及手段。现就近年来SS治疗药物作一综述,以期为临床用药提供一定参考。

干燥综合征  /  自身免疫性疾病  /  靶向药物

Sjögren syndrome (SS) is a chronic autoimmune disease characterized by destruction of exocrine glandular epithelium and severe drying of mucosal surface, with complex etiology. It is difficult to diagnose SS accurately because of its extensive manifestations and overlapping of signs and symptoms with other autoimmune diseases. At present, substitution and symptomatic treatment are mainly used in clinic to delay the disease and improve symptoms, but the effect is often not ideal, and there is no radical cure. In recent years, with the continuous development of various targeted drugs, some new theatments and means have emerged in the clinical treatment of SS. This article reviewed the therapeutic drugs of SS in recent years in order to provide reference for clinical medication.

Sjögren syndrome  /  autoimmune disease  /  targeted drug
孙丽丽, 张艳艳, 潘绵立, 沈龙海. 干燥综合征治疗药物研究进展. 世界临床药物, 2022 , 43 (7) : 932 -938 . DOI: 10.13683/j.wph.2022.07.021
Lili SUN, Yanyan ZHANG, Mianli PAN, Longhai SHEN. Progress on the study of therapeutic drugs for Sjögren syndrome[J]. World Clinical Drug, 2022 , 43 (7) : 932 -938 . DOI: 10.13683/j.wph.2022.07.021

参考文献 引证文献
排序方式:
[1]
Yue X, Deng F, Chen J, et al. Autoantibodies against C5aR1, C3aR1, CXCR3, and CXCR4 are decreased in primary Sjögren's syndrome[J]. Mol Immunol, 2021, 131: 112-120.
[2]
Fisher BM, Brown RM, Bowman SJ, et al. A review of salivary gland histopathology in primary Sjögren's syndrome with a focus on its potential as a clinical trials biomarker[J]. Ann Rheum Dis, 2015, 74(9): 1645-1650.
[3]
Luo D, Chen Y, Zhou N, et al. Blockade of Th17 response by IL-38 in primary Sjögren's syndrome[J]. Mol Immunol, 2020, 127: 107-111.
[4]
Rui K, Hong Y, Zhu Q, et al. Olfactory ecto-mesenchymal stem cell-derived exosomes ameliorate murine Sjögren's syndrome by modulating the function of myeloid-derived suppressor cells[J]. Cell Mol Immunol, 2021, 18(2): 440-451.
[5]
Wieczorek G, Bigaud M, Pfister S, et al. Blockade of CD40-CD154 pathway interactions suppresses ectopic lymphoid structures and inhibits pathology in the NOD/ShiLtJ mouse model of Sjögren's syndrome[J]. Ann Rheum Dis, 2019, 78(7): 974-978.
[6]
Qin B, Wang J, Yang Z, et al. Epidemiology of primary Sjögren's syndrome: a systematic review and meta-analysis[J]. Ann Rheum Dis, 2015, 74(11): 1983-1989.
[7]
Mavragani CP. Mechanisms and new strategies for primary Sjögren's syndrome[J]. Annu Rev Med, 2017, 68: 331-343.
[8]
Betül Türkoğlu E, Tuna S, Alan S, et al. Effect of systemic infiximab therapy in patients with Sjögren's syndrome[J]. Turk J Ophthalmol, 2015, 45(4): 138-141.
[9]
St Clair EW, Baer AN, Wei C, et al. The clinical efficacy and safety of baminercept, a lymphotoxin-β receptor fusion protein, in primary Sjögren's syndrome: results from a randomized, double-blind, placebo-controlled phase Ⅱ trial[J]. Arthritis Rheumatol, 2018, 70(9): 1470-1480.
[10]
Nakahara H, Kawamoto K, Mori H, et al. AB0485 tocilizumab is effective for the patient with Sjogren's syndrome complicated with rheumatoid arthritis[J]. Ann Rheum Dis, 2014, 73(Suppl 2): 967-968.
[11]
Marino A, Narula S, Lerman MA. First pediatric patient with neuromyelitis optica and Sjögren's syndrome successfully treated with tocilizumab[J]. Pediatr Neurol, 2017, 73: e5-e6.
[12]
Maier-Moore JS, Horton CG, Mathews SA, et al. Interleukin-6 deficiency corrects nephritis, lymphocyte abnormalities, and secondary Sjögren's syndrome features in lupus-prone Sle1. Yaa mice[J]. Arthritis Rheumatol, 2014, 66(9): 2521-2531.
[13]
Barone F, Nayar S, Campos J, et al. IL-22 regulates lymphoid chemokine production and assembly of tertiary lymphoid organs[J]. Proc Natl Acad Sci USA, 2015, 112(35): 11024-11029.
[14]
Bowman SJ, Everett CC, O'Dwyer JL, et al. Randomized controlled trial of rituximab and cost-effectiveness analysis in treating fatigue and oral dryness in primary Sjögren's syndrome[J]. Arthritis Rheumatol, 2017, 69(7): 1440-1450.
[15]
Mekinian A, Ravaud P, Hatron PY, et al. Efficacy of rituximab in primary Sjögren's syndrome with peripheral nervous system involvement: results from the AIR registry[J]. Ann Rheum Dis, 2012, 71(1): 84-87.
[16]
Steinfeld SD, Tant L, Burmester GR, et al. Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase Ⅰ/Ⅱ study[J]. Arthritis Res Ther, 2006, 8(4): R129.
[17]
Mariette X, Seror R, Quartuccio L, et al. Efficacy and safety of belimumab in primary Sjögren's syndrome: results of the BELISS open-label phase Ⅱ study[J]. Ann Rheum Dis, 2015, 74(3): 526-531.
[18]
Tsuboi H, Matsumoto I, Hagiwara S, et al. Efficacy and safety of abatacept for patients with Sjögren's syndrome associated with rheumatoid arthritis: rheumatoid arthritis with orencia trial toward Sjögren's syndrome endocrinopathy (ROSE) trial-an open-label, one-year, prospective study- interim analysis of 32 patients for 24 weeks[J]. Mod Rheumatol, 2015, 25(2): 187-193.
[19]
Corneth OBJ, Verstappen GMP, Paulissen SMJ, et al. Enhanced Bruton's tyrosine kinase activity in peripheral blood B lymphocytes of autoimmune disease patients[J]. Arthritis Rheumatol, 2017, 69(6): 1313-1324.
2022年第43卷第7期
18
5
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2022.07.021
  • 接收时间:2021-07-14
  • 首发时间:2026-11-19
  • 出版时间:2022-07-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2021-07-14
基金
作者信息
    上海医药工业研究院有限公司,上海医药工业研究院创新药物与制药工艺国家重点实验室,上海市生物物质成药性评价和专业技术服务平台,上海 200437

通讯作者:

沈龙海,研究员,研究方向:免疫药理学。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2022.07.021
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏